湖南省启动艾滋病耐药因素哨点监测


湖南省启动艾滋病耐药因素哨点监测

 
 
 
 
 

湖南省启动艾滋病耐药因素哨点监测
    来源:http://900120.com  时间: 2011-01-23  】
    日前,从湖南省疾控中心了解,中国疾控部门正式启动全球基金艾滋病项目HIV耐药哨点监测项目(以下简称:RCC耐药哨点监测项目),包括湖南在内的10个项目省即将开展HIV耐药哨点监测工作。

    据了解,我国从2003年开始在全国范围内逐步实施免费的艾滋病抗病毒治疗。然而,艾滋病病毒感染的治疗是终身性的,在我国抗病毒治疗药品国产品种有限,艾滋病耐药的产生将会是一个最终无法避免的问题。因此,开展艾滋病抗病治疗点的耐药群体性监测,及时监测艾滋病病毒耐药产生的情况及其相关因素是我国一个重要的策略性工作。

     HIV耐药哨点监测工作,将通过对艾滋病抗病毒治疗人群开展前瞻性队列随访,阐明病毒抑制失败人群中HIV耐药程度和突变情况,以及耐药发生的影响因素,为制定HIV耐药预防策略提供科学数据。

 
图示∶2010年12月即将出版的《中国特色医疗金鉴》登载的刘君主任及其机构 
 
 

慢性艾滋病早期中医药治疗保障生命论证

红津液饮料面世 或将能预防艾滋病

更多来源∶新浪商业登载
http://vic.sina.com.cn/news/27/2010/1231/26801.html


TOM新闻登载

http://post-social.news.tom.com/s/63000AD83310.html

中国青年网 健康频道

http://news.youth.cn/jk/201012/t20101231_1447239.htm

 环球时报-环球网

http://news.163.com/10/1231/15/6P8B7PTU00014JB6.html


 环球网

http://china.huanqiu.com/hot/2010-12/1390550.html

Hunan start sentinel surveillance of HIV drug resistance factors
     Source: http://900120.com time: 2011-01-23
     Recently, the CDC know from Hunan Province, China, disease control departments launched Global Fund AIDS Program HIV drug resistance sentinel surveillance project (hereinafter referred to as: RCC resistance sentinel surveillance project), including 10 projects in Hunan province, including about HIV drug resistance sentinel surveillance carried out the work.

     It is understood that our country since 2003, gradually implemented throughout the country free of HIV antiretroviral therapy. However, the treatment of HIV infection is lifelong, and in our domestic varieties of anti-viral treatment drugs are limited, the production of HIV drug resistance will be a final can not avoid. Therefore, the treatment of AIDS disease monitoring point of resistance groups, timely monitoring of HIV drug resistance and its related factors produced in China is an important strategic work.

      Sentinel surveillance of HIV drug resistance work through anti-viral treatment of AIDS among population prospective cohort follow-up, the crowd failed to clarify viral suppression and mutation of HIV drug resistance levels, as well as the impact of drug resistance factors for the development of HIV drug resistance prevention Strategy for scientific data.

 
 
 
 
 

[ 作者:佚名    转贴自:本站原创    点击数:196    更新时间:2011-1-24    文章录入:nnb ]